Previous 10 | Next 10 |
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
BERWYN, Pa., July 23, 2020 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, today announced its CEO, Maria Maccecchini, Ph...
DPW Holdings (NYSEMKT: DPW ) +136% on introducing a new product line of electric vehicle chargers. More news on: DPW Holdings, Inc., Sonnet BioTherapeutics Holdings, Inc., Volt Information Sciences, Inc., Stocks on the move, , Read more ...
BERWYN, Pa., July 20, 2020 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, is pleased to announce its CEO Maria Maccecchini, P...
MOGU (NYSE: MOGU ) -14% . More news on: MOGU Inc., Ascena Retail Group, Inc., Fuel Tech, Inc., Stocks on the move, , Read more ...
Gainers: Corvus Pharmaceuticals (NASDAQ: CRVS ) +108% . More news on: Corvus Pharmaceuticals, Inc., Annovis Bio, Inc., Hepion Pharmaceuticals, Inc., Stocks on the move, , Read more ...
Thinly traded nano cap Annovis Bio ( ANVS +77.3% ) jumps on a whopping 506x surge in volume in reaction to its announcement that it has secured IRB approval to proceed with a 15-site clinical trial evaluating lead drug ANVS401 in Alzheimer's and Parkinson's patients. More news on: Anno...
3 Penny Stocks To Watch Before The Weekend There are never dull moments with penny stocks . Most of the time, these stocks under $5 have a proper mix of speculative momentum and fundamental catalysts that can see huge moves. Sometimes these moves are long-lasting while other times they’...
Corvus Pharmaceuticals (NASDAQ: CRVS ) +103% on launch immunotherapy study for COVID-19. More news on: Corvus Pharmaceuticals, Inc., Annovis Bio, Inc., Novavax, Inc., Stocks on the move, , Read more ...
BERWYN, Pa., July 07, 2020 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, reported that it has received Central Institutional...
News, Short Squeeze, Breakout and More Instantly...
Annovis Bio (NYSE: ANVS) , a late-stage, drug-platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (“AD”) and Parkinson’s disease (“PD”), today announced the receipt of U.S. Patent No. 12,042,482. The patent ...
MALVERN, Pa., July 24, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’...
The new executive team includes Mark White, Alexander Morin, Hilda Maibach, and Blake Jensen These additions are pivotal as the company makes strides toward bringing flagship drug candidate buntanetap closer to New Drug Application (“NDA”) status and to market Annovis Bio (NYS...